Hemostatic Textile to Control Bleeding at Donor Graft Sites
Stasilon
Use of a HemostaticTextile (StasilonTM) to Control Bleeding at Skin Graft Donor Sites (Randomized, Single-Blind)
1 other identifier
observational
20
1 country
1
Brief Summary
The rationale underlying the study is that donor site bleeding is common and often problematic when presenting to the burn surgeon or staff. Frequently, gauze wound dressings are not sufficiently hemostatic to control a donor site bleed thereby leading to administration of vasoconstrictive agents and repeated application of wound dressing/pressure. The hemostatic textile Stasilon™ has proven superior to gauze in reducing bleeding from anesthetized pigs undergoing standardized surgically-induced trauma. Also, observational case reports have noted cessation of bleeding in a limited number of human patients with difficult to control bleeds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 2, 2009
CompletedFirst Posted
Study publicly available on registry
March 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedDecember 12, 2017
June 1, 2012
2.3 years
March 2, 2009
December 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the efficacy of a new hemostatic textile named Stasilon™ against standard wound dressings in controlling burn patient donor graft site bleeding.
At the time of surgery
Study Arms (1)
1
Each donor site will act as it own control - both dressings will be applied to the donor site and assessments will be made
Interventions
Stasilon and gauze will be applied to donor site. Dressings will be collected and evaluated for amount of shed blood.
Eligibility Criteria
Patients admitted to the UNC Jaycee Burn Center
You may qualify if:
- \>/= 18 years old
- burn injury requiring allografting from donor site
You may not qualify if:
- \< 18 years
- unable to give consent due to mental or emotional instability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Carolina Jaycee Burn Center
Chapel Hill, North Carolina, 27514, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Preston Rich, MD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2009
First Posted
March 4, 2009
Study Start
June 1, 2008
Primary Completion
September 1, 2010
Study Completion
December 1, 2010
Last Updated
December 12, 2017
Record last verified: 2012-06